Therefore, understanding the changes in ATF3 expression in the aqueous humor or serum of RIR mice and the blood of patients with different degrees of glaucoma will reveal whether ATF3 can be employed as a clinical diagnostic or prognostic marker for optic neurodegenerative diseases. This evidence concerns the gene ATF3 and glaucoma.